Outlook Therapeutics (OTLK) Capital Expenditures (2015 - 2019)
Outlook Therapeutics' Capital Expenditures came in at $1.00 for fiscal Q4 2019 (quarter ended Sep 30, 2019), down 100.0% from $1.26 million a year earlier and down 100.0% from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Capital Expenditures (2015 - 2019) Analysis & Trends
For FY2019 (ended Sep 30, 2019), Outlook Therapeutics' Capital Expenditures was $437,307, down 84.3% from FY2018.
- Capital Expenditures carries a four-year compound annual growth rate of -52.8% (FY2015 to FY2019).
- Going back by fiscal year, Capital Expenditures was $2.78 million in FY2018 (+852.2%), $292,086 in FY2017 (-73.4%), $1.1 million in FY2016 (-87.5%) and $8.8 million in FY2015.
- The fiscal Q4 2019 figure represents the lowest quarterly Capital Expenditures since fiscal Q2 2016.
- Year-over-year, Capital Expenditures has declined for four consecutive quarters, with growth averaging 143.9% over the last seven quarters.
- The fastest year-over-year change in Capital Expenditures over five years came in fiscal Q1 2018 (growth of 624.7%), and the weakest in fiscal Q4 2019 (a decline of 100.0%).
- Business Quant data shows OTLK's Capital Expenditures at $150,737 (Q3 2019), $50,136 (Q2 2019) and $236,433 (Q1 2019) in the three fiscal quarters before Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.82 Bn | 1,135.41 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 644.52 Bn | 564.38 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 501.88 Bn | 474.99 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 358.72 Bn | 313.10 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 302.27 Bn | 266.26 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 267.62 Bn | 241.31 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 241.67 Bn | 197.07 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 193.09 Bn | 167.28 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 171.60 Bn | 118.24 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Outlook Therapeutics | 76.34 Mn | 40.59 Mn | -8,265.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 1.00 |
| Jun 30, 2019 | 150,737.00 |
| Mar 31, 2019 | 50,136.00 |
| Dec 31, 2018 | 236,433.00 |
| Sep 30, 2018 | 1.26 Mn |
| Jun 30, 2018 | 168,020.00 |
| Mar 31, 2018 | 275,186.00 |
| Dec 31, 2017 | 1.08 Mn |
| Sep 30, 2017 | 23,980.00 |
| Jun 30, 2017 | 76,229.00 |
| Mar 31, 2017 | 43,515.00 |
| Dec 31, 2016 | 148,362.00 |
| Sep 30, 2016 | 328,411.00 |
| Jun 30, 2016 | 452,476.00 |
| Mar 31, 2016 | -46,949.00 |
| Dec 31, 2015 | 364,242.00 |
| Sep 30, 2015 | 3.29 Mn |
| Jun 30, 2015 | 3.49 Mn |
API Access
Outlook Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();